Medulloblastoma: clinicopathological correlates of SHH, WNT, and non-SHH/WNT molecular subgroups.
about
Pediatric medulloblastoma - update on molecular classification driving targeted therapiesVoltage-gated potassium channel EAG2 controls mitotic entry and tumor growth in medulloblastoma via regulating cell volume dynamicsMolecular subgroups of medulloblastoma: the current consensusMicroRNA Regulation of Brain Tumour Initiating Cells in Central Nervous System TumoursAdaptations of energy metabolism during cerebellar neurogenesis are co-opted in medulloblastomaCasein kinase 1δ is an APC/C(Cdh1) substrate that regulates cerebellar granule cell neurogenesis.Genome sequencing of SHH medulloblastoma predicts genotype-related response to smoothened inhibitionVismodegib Exerts Targeted Efficacy Against Recurrent Sonic Hedgehog-Subgroup Medulloblastoma: Results From Phase II Pediatric Brain Tumor Consortium Studies PBTC-025B and PBTC-032.Young investigator challenge: Cytomorphologic analysis of cerebrospinal fluid in 70 pediatric patients with medulloblastoma and review of the literature focusing on novel diagnostic and prognostic testsMicroRNAs in pediatric central nervous system embryonal neoplasms: the known unknownDNA methylation profiling of medulloblastoma allows robust subclassification and improved outcome prediction using formalin-fixed biopsiesG-protein coupled receptor expression patterns delineate medulloblastoma subgroupsComputer-assisted quantification of motile and invasive capabilities of cancer cells.Management of pediatric and adult patients with medulloblastoma.Clinical, pathological, and molecular data on desmoplastic/nodular medulloblastoma: case studies and a review of the literature.RITA displays anti-tumor activity in medulloblastomas independent of TP53 status.Molecular Testing of Brain Tumor.Medulloblastoma in China: clinicopathologic analyses of SHH, WNT, and non-SHH/WNT molecular subgroups reveal different therapeutic responses to adjuvant chemotherapy.A neuropathology-based approach to epilepsy surgery in brain tumors and proposal for a new terminology use for long-term epilepsy-associated brain tumors.Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and Group 4 medulloblastomas.Recurrent carotico-cavernous fistula after internal carotid artery ligation: a case with embolization of the fistula via contralateral internal carotid artery approachNeuroradiology and histopathology in two cases of adult medulloblastoma.A microRNA-1280/JAG2 network comprises a novel biological target in high-risk medulloblastoma.Overcoming multiple drug resistance mechanisms in medulloblastoma.WNT activation by lithium abrogates TP53 mutation associated radiation resistance in medulloblastomaImproved health-related quality of life outcomes associated with SHH subgroup medulloblastoma in SIOP-UKCCSG PNET3 trial survivorsYes-associated protein 1 is widely expressed in human brain tumors and promotes glioblastoma growth.Molecular subgroups of medulloblastoma.Gene expression by simian virus 40 large T antigen-induced medulloblastomas in mice.Contrast enhancement pattern predicts poor survival for patients with non-WNT/SHH medulloblastoma tumours.Wnt pathway in atypical teratoid rhabdoid tumors.Rapid, reliable, and reproducible molecular sub-grouping of clinical medulloblastoma samplesTargeting Notch, Hedgehog, and Wnt pathways in cancer stem cells: clinical updateGlobal gene expression profiling confirms the molecular fidelity of primary tumor-based orthotopic xenograft mouse models of medulloblastoma.Myc proteins in brain tumor development and maintenance.The molecular classification of medulloblastoma: driving the next generation clinical trials.Pediatric and adult sonic hedgehog medulloblastomas are clinically and molecularly distinct.Distinct neural stem cell populations give rise to disparate brain tumors in response to N-MYC.Early recurrence in standard-risk medulloblastoma patients with the common idic(17)(p11.2) rearrangementAnomalous vascularization in a Wnt medulloblastoma: a case report.
P2860
Q21129295-58C41938-8E0E-4E67-9D2A-E6FBA115BBF4Q24294672-08597D9D-D339-430E-BE5E-B28AB2B9199CQ24615271-ACBBB336-CB71-468F-A8E1-D9B75E31C8BBQ27002604-B89140C9-BF85-4640-B6F1-FA37C1BBEB6AQ27015699-AA62E82F-6A3A-4BAA-AA5A-FCE602825C9CQ27320896-86A6D018-E6D8-44BF-80BE-FC3192702222Q27852966-DBC4FA2D-7DAC-46BF-A0A3-1484A5B06090Q27853187-4D54F52C-FCA6-48D7-BBDD-6F0B94DF13FCQ28080016-91287CED-FEB7-499D-B3A9-10F841D5EA36Q28083277-FE5A18C7-C142-4241-8436-C80E793F4682Q28282708-D115556F-6411-4B65-BAE6-9A0817389AD7Q28302285-D141B716-4D36-4CE2-9576-4854F639D365Q30669870-82133B22-8976-4B79-BB1E-A71BA77E1978Q30847947-0490D1DC-8833-4912-939C-16563DB5BB63Q31043687-86508D7C-7253-4561-B097-56706DEF4AC8Q33709483-4162504A-2020-4A56-871A-F62590F7789EQ33729693-B2F2EC23-1343-4B90-81E6-CF8C51EA62D6Q33763291-FBDADEED-95B2-4FB4-B99A-666FC1D618C5Q33764533-C4F2A3DF-CAB5-4E9D-BBD4-44CB6955D80AQ34167499-E841D3CF-C9A2-432A-B0C0-986CA3C0C00EQ34296928-BC0C5B34-0A3D-466D-BE9A-2B5FF08EC1EEQ34369671-151BD6A0-F36B-48A1-ADFE-91D74C32F8B3Q34457533-0C80FE66-B2B6-449A-AE62-85DE55FAC3FAQ34500602-B63AAE98-A9DD-445B-AF61-913CFFB8E546Q34979270-1CB472BF-44B4-4059-A738-551B2350F601Q35035502-98FC9E1D-7978-4A5A-816C-9FC10F052FDFQ35089015-C76417E5-579B-4DE0-ACBD-F5E08127B2E3Q35101347-1CCFC973-46AA-4F37-9057-37A012974FF6Q35123804-78F0593E-3962-40EB-8ED0-39E50AB66472Q35630417-A2A909B2-9433-4C99-BAF0-BE86C47C54BCQ35788801-4EFCFDEF-364A-4F30-9EB4-645BED42DB0FQ35837393-52658CE8-60E6-4BBA-8FA9-0B0769253FEEQ35904534-1E205624-EA2C-433C-AAD8-72A87CEEF796Q35914511-8A7DF85F-F630-4009-B176-FE795E35082EQ35920494-B775FBCD-9E1F-41A5-B88C-2A025F354742Q35946293-50F8F077-CFA1-4AA8-9167-260E4D841D4EQ35960250-EACE7674-AC35-44B3-858C-863E00B856DBQ35989886-B72588B5-A832-4C54-B044-CAA48921C5E2Q36048155-09E4CADA-4301-4587-8953-5EA83D80D800Q36077998-D18A5109-7403-478F-902B-3EA32F8BC10A
P2860
Medulloblastoma: clinicopathological correlates of SHH, WNT, and non-SHH/WNT molecular subgroups.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Medulloblastoma: clinicopathol ...... n-SHH/WNT molecular subgroups.
@ast
Medulloblastoma: clinicopathol ...... n-SHH/WNT molecular subgroups.
@en
type
label
Medulloblastoma: clinicopathol ...... n-SHH/WNT molecular subgroups.
@ast
Medulloblastoma: clinicopathol ...... n-SHH/WNT molecular subgroups.
@en
prefLabel
Medulloblastoma: clinicopathol ...... n-SHH/WNT molecular subgroups.
@ast
Medulloblastoma: clinicopathol ...... n-SHH/WNT molecular subgroups.
@en
P2093
P2860
P1476
Medulloblastoma: clinicopathol ...... n-SHH/WNT molecular subgroups.
@en
P2093
Anna M Kenney
Charles Fraga
Dan J Brat
David W Ellison
Geoff Neale
James Dalton
Richard J Gilbertson
Roger E Taylor
Sarah Leigh Nicholson
Simon Bailey
P2860
P2888
P304
P356
10.1007/S00401-011-0800-8
P577
2011-01-26T00:00:00Z